PHARMATEK · Gastroentérologie

Calculateur du score BARD original

Calculer la somme originale BARD de 0 à 4 et le détail des composantes à partir de l’IMC vérifié, de l’ASAT/ALAT du même prélèvement et d’un statut diabétique explicite.

Révision clinique en cours

La révision clinique doit être complétée.

Cet outil fait partie de la bibliothèque PharmaTek. Son calcul reste indisponible au public jusqu’à la validation de sa formule, de ses limites et de ses sources.

Explorer les outils accessibles

Sources, population et validation

État: clinical-review-pending
Version de la méthode: Harrison 2008 original BARD point arithmetic v1: BMI >= 28 kg/m² contributes 1 point; AST/ALT ratio >= 0.8 contributes 2 points; independently established generic diabetes mellitus present contributes 1 point; otherwise each component contributes zero; integer total 0–4; both numeric boundaries are inclusive
Population: Adults for whom applicability of the original retrospective, biopsy-characterized NAFLD source context is independently established. The original study analyzed 827 patients at two geographically separate US tertiary centers. BMI and generic diabetes mellitus status must be independently verified; AST and ALT must be contemporaneous same-specimen results in U/L with compatible assay identities. The accessible primary abstract does not expose the operational diabetes definition, so status must not be inferred from glucose or HbA1c by this calculator.
Limites et exclusions: The source paper's 0–1 versus 2–4 grouping, any cutoff-based interpretation, fibrosis category or conclusion, advanced-fibrosis classification, probability, predictive value, odds ratio, diagnosis, prognosis, reassurance, biopsy decision, management, monitoring, treatment, or other clinical decision. · Automatic equivalence between the original biopsy-characterized NAFLD source setting and a modern MASLD definition; pediatric use; primary-care, lean, Asian, or other population extrapolation without independently established applicability; or any claim of portable performance. · Inferring diabetes mellitus from glucose, HbA1c, medication data, or another proxy; substituting impaired fasting glucose for the generic diabetes component; or silently selecting an operational diabetes definition not exposed in the accessible primary abstract. · Mismatched specimens, non-contemporaneous AST and ALT, incompatible assay or unit identities, inferred units, silently reinterpreted values, derived BMI not independently verified, or incomplete component data.

Origine de l’outil PharmaTek

Outil importé de la bibliothèque PharmaTek de MDose. Aucune date de révision clinique indépendante n’est documentée dans cette version.

Bibliothèque source: PharmaTek · MDose
Version importée: 4b66536936ed
État de publication: Révision clinique en cours

POURSUIVRE AVEC MDOSE

Un outil. Un premier lien.

Recevez des nouvelles des outils ou discutez d’une collaboration. L’utilisation de PharmaTek reste accessible sans laisser vos coordonnées.

Médecins et partenaires